Cryo-Cell International (CCEL) Cash Flow: Operating & Free Cash Flow

Cryo-Cell International (CCEL) Cash Flow Statement

In fiscal 2025 (fiscal year ended Nov 30, 2025), Cryo-Cell International generated $5.48M of operating cash flow and spent $230.47K on capital expenditures. That left free cash flow of $5.25M, up 118.0% from $2.41M a year earlier, or 16.6% of revenue. It returned $3.40M to shareholders through $3.23M in dividends and $169.50K in share buybacks.

Cryo-Cell International Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Cryo-Cell International, Inc. (CCEL) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Nov 2025	Feb 2025	Nov 2024	Nov 2023	Feb 2023	Nov 2022	Nov 2021	Nov 2020	Nov 2019	Nov 2018	Nov 2017
Operating Activities
Net Income	-2.43	0.40	0.40	-9.52	2.77	2.77	2.08	3.62	2.29	-0.85	2.32
Depreciation & Amortization	0.99	1.02	1.02	1.71	1.81	1.81	1.33	0.64	0.40	0.32	0.23
Deferred Income Tax	-2.82	-0.31	-0.31	-6.75	-1.73	-1.73	-1.65	-1.28	-1.52	2.38	-0.77
Stock Based Compensation	0.42	0.78	0.78	0.82	0.46	0.46	0.30	0.62	0.40	0.48	0.97
Change in Working Capital	2.84	3.70	3.70	5.99	4.25	4.25	4.86	3.76	2.28	2.43	2.77
Change in Accounts Receivable	-0.41	-2.00	-2.00	-1.57	-1.72	-1.72	0.53	-0.83	-1.00	-1.35	-1.15
Change in Inventory	0.06	0.43	0.43	0.36	0.49	0.49	0.21	0.45	-0.03	0.32	0.05
Change in Accounts Payable	1.00	-0.42	-0.42	0.69	0.12	0.12	0.53	-0.41	0.11	-0.67	0.44
Change in Other Working Capital	-0.64	5.69	0.02	6.50	5.37	0.45	3.58	4.54	3.20	4.13	3.43
Other Operating Activities	3.67	0.42	0.02	16.68	1.01	0.45	1.00	1.11	2.47	0.58	0.20
Net Cash from Operating Activities	5.48	6.01	6.01	8.92	8.57	8.57	7.93	8.47	6.32	5.33	5.72
Investing Activities
Capital Expenditures	-0.23	-3.60	-3.60	-7.64	-17.17	-17.17	-6.95	-0.45	-0.66	-0.65	-0.10
Acquisitions	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00	-10.50	0.00
Purchases of Investments	-3.65	-2.89	-2.89	-1.08	-1.14	-1.14	0.00	0.00	-0.03	0.00	0.00
Sales/Maturities of Investments	2.79	1.62	1.62	0.58	1.16	1.16	0.00	0.81	0.00	0.00	0.00
Other Investing Activities	0.12	-1.20	-	-0.80	1.87	-	0.00	0.00	0.00	-0.14	0.19
Net Cash from Investing Activities	-0.98	-4.88	-4.88	-8.14	-15.28	-15.28	-6.95	0.36	-0.69	-11.28	0.09
Financing Activities
Debt Repayment	-0.15	2.16	-3.06	-1.21	9.29	-7.35	-4.10	-3.10	-4.10	5.71	-2.65
Common Stock Issued	0.02	0.08	0.08	0.00	0.00	0.55	0.00	0.00	0.00	0.00	0.00
Common Stock Repurchased	-0.17	-1.42	-1.42	-0.80	-1.82	-1.82	-0.25	0.00	-0.99	0.00	-0.45
Dividends Paid	-3.23	-2.02	-2.02	0.00	-7.67	-7.67	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	0.00	0.23	0.23	-0.07	0.35	-0.20	1.28	-1.90	-0.04	0.00	0.06
Net Cash from Financing Activities	-4.75	-0.98	-0.98	-2.07	0.15	0.15	-3.07	-5.00	-5.13	5.71	-3.03
Summary
Net Change in Cash	-0.24	0.15	0.15	-1.30	-6.56	-6.56	-2.10	3.82	0.50	-0.24	2.78
Cash at Beginning of Period	0.56	0.41	0.41	1.70	8.26	8.26	10.36	6.54	6.04	6.28	3.50
Cash at End of Period	0.32	0.56	0.56	0.41	1.70	1.70	8.26	10.36	6.54	6.04	6.28
Free Cash Flow	5.25	2.41	2.41	1.28	-8.60	-8.60	0.97	8.02	5.66	4.69	5.62
Supplemental Disclosures
Interest Paid	-	-	1.98	1.81	-	1.26	1.04	0.31	-	-	-
Income Taxes Paid	-	-	2.72	1.82	-	1.57	3.53	1.88	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Aug 31, 2026. Data sources and methodology

Frequently Asked Questions About Cryo-Cell International Cash Flow

What is Cryo-Cell International's free cash flow?

Cryo-Cell International generated free cash flow of $5.25M in fiscal 2025 (fiscal year ended Nov 30, 2025), operating cash flow of $5.48M minus $230.47K of capital expenditures. That was up 118.0% from $2.41M a year earlier. Free cash flow equaled 16.6% of revenue.

How much does Cryo-Cell International spend on capital expenditures?

Cryo-Cell International spent $230.47K on capital expenditures in fiscal 2025, compared with $3.60M a year earlier. That equals 4.2% of operating cash flow.

Does Cryo-Cell International pay dividends or buy back shares?

Yes. In fiscal 2025 Cryo-Cell International returned $3.23M in dividends and $169.50K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition